Live Stream:
Thursday, August 4, 2022
Course# MEP23001
Registration Fees
Physicians $350
Nurses/Physician Assistances/ Advanced Health Care Practitioners $300
Residents/Fellows $250
Registration fee discounts are available for Kaiser and UCSF CCMBM faculty.
Please contact Lucy Wu at [email protected] for more information.
Cancellations received in writing before August 1, 2022 will be refunded, less a $75 administrative fee. No refunds will be made on cancellations received after that date. Please email your requests to [email protected]
Overview
Now in its 19th year, and presented by the department of epidemiology and Biostatistics of the University of California, San Francisco School of Medicine, this 1-day virtual course features an expert faculty that will discuss the epidemiology, pathophysiology, diagnosis, and treatment of osteoporosis. Specific topics will include the cell biology of osteoporosis, bone biomechanics, endocrine and nutrition aspects of osteoporosis, and advances in skeletal imaging. The course will also critically review current treatment options and preview new treatments. There will be an emphasis on recent developments and current controversies in the etiology, diagnosis, and management of osteoporosis.
TARGET AUDIENCE
The course will provide an update on current recommendations about screening and treatment of osteoporosis for physicians and other clinicians working with osteoporosis patients. It will also benefit researchers, technologists and pharmaceutical or device company professionals who would find additional scientific background in the disease helpful. This year the conference will focus on the latest clinical updates and controversies about diagnosis and pharmacologic therapies. No prior clinical or scientific training in osteoporosis is required.
LIVE STREAM MEETING
This course will be offered as a virtual conference. Login instructions along with the digital syllabus will be shared with the attendees a week before the meeting. Included in your registration fee is access to the course recordings on demand (Available within a week after the conference) for any session that you miss, available for 30 days after the course.
Educational Objectives
An attendee completing this course will be able to:
- Provide appropriate pharmacological treatment for osteoporosis, including antiresorptive and anabolic therapies, separately or in combination;
- Assess the benefits and risks of long-term antiresorptive osteoporosis therapy and determine optimal treatment duration;
- Perform a diagnostic evaluation of skeletal fragility when a congenital or acquired disorder other than osteoporosis is suspected;
- Describe the approach to osteoporosis in the geriatric population;
- Understand best practices and interpretation of dual-energy X-ray absorptiometry (DXA) scans.
Accreditation
The University of California, San Francisco School of Medicine (UCSF) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
UCSF designates this live activity for a maximum of 11.25 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Geriatric: The approved credits shown above include 11.25 credits toward meeting the requirement under California Assembly Bill 1820, Geriatric Medicine.
Nurses: For the purposes of recertification, the American Nurses Credentialing Center accepts AMA PRA Category 1 CreditsTM issued by organizations accredited by the ACCME.
Physician Assistants: AAPA accepts category 1 credit from AOACCME, Prescribed credit from AAFP, andAMA PRA Category 1 CreditsTM from organizations accredited by the ACCME.
American Board of internal Medicine (ABiM) MOC: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 11.25 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Course Outline
| Thursday, August 4, 2022 | ||
| ANTIRESORPTIVE TREATMENT | ||
| 8:00 AM | Zoom Registration and login, housekeeping, overview | |
| 8:10 | Bisphosphonate Efficacy, Duration, and Drug Holidays: Maximize Benefits and Minimize Risk | Dennis M. Black, PhD |
| 8:45 | Q&A | |
| 8:55 | Long-Term Treatment With and Following Denosumab | Richard Eastell, MD, FRCP |
| 9:25 | Q&A | |
| 9:35 | Break | |
| ANABOLIC TREATMENT | ||
| 9:50 | Accurate Diagnosis of Vertebral Fracture | Richard Eastell, MD, FRCP |
| 10:10 | Q&A | |
| 10:20 | Anabolic Agents: Efficacy and Safety | Clifford J. Rosen, MD |
| 10:55 | Incorporating Anabolic Treatments into Osteoporosis Regimens | Anne L. Schafer, MD |
| 11:25 | Q&A | |
| 11:35 | The Future of Osteoporosis Trials: FNIH-FDA Project | Dennis M. Black, PhD |
| 11:55 | Q&A | |
| 12:00 PM | Lunch Break | |
| SPECIAL TOPICS IN OSTEOPOROSIS | ||
| 1:00 PM | When is Skeletal Fragility Not Osteoporosis? | |
| Part 1: Acquired Causes of Skeletal Fragility | Deborah Sellmeyer, MD | |
| 1:25 | Part 2: Genetic Causes of Skeletal Fragility | Edward Hsiao, MD, PhD |
| 1:45 | Q&A | |
| 1:55 | Osteoporosis in the Geriatric Population | Deborah Kado, MD |
| 2:20 | Q&A | |
| 2:30 | Break | |
| 2:40 | DXA Interpretation and Pitfalls | Deborah Sellmeyer, MD |
| 3:10 | Q&A | |
| 3:20 | Clinical Roundtable: Q&A with a Panel of Physicians | Deborah E. Sellmeyer, MD Anne L. Schafer, MD Clifford J. Rosen, MD Steven T. Harris, MD, FACP, FASBMR |
| 3:50 | Adjourn | |
| RECORDED CONTENT | ||
| 33:40:00 | Basics of Bone Biology | Daniel Bikle, MD, PhD |
| 33:30:00 | Epidemiology and Consequences of Fractures | Ann V. Schwartz, PhD |
| 40:44:00 | Osteoporosis Screening and Diagnosis: BMD, FRAX and Assessment of Secondary Osteoporosis | Steven T. Harris, MD, FACP, FASBMR |
| 25:39:00 | Calcium Intake | Anne L. Schafer, MD |
| 41:47:00 | Vitamin D | Clifford Rosen, MD |
| 23:11 | Physical Activity for Skeletal Health | Wendy L. Katzman, PT, DPTSc |
| 45:00:00 | Monitoring: Before, During and After Treatment | Doug C. Bauer, MD |
| 35:57:00 | Glucocorticoid-Induced Osteoporosis | Jonathan Graf, MD |
Course Chairs
Dennis M. Black, PhD
Professor of Epidemiology and Biostatistics
University of California, San Francisco
Anne L. Schafer, MD
Associate Professor of Medicine and of
Epidemiology and Biostatistics
University of California, San Francisco
Chief of Endocrinology and Metabolism,
San Francisco VA Health Care System
Faculty
(University of California, San Francisco, unless otherwise noted)
Doug C. Bauer
Daniel Bikle, MD, PhD
Professor of Medicine
Richard Eastell, MD, FRCP
Professor and Head of the Academic Unit of Bone Metabolism
Director of the Mallanby Centre for Bone Research, University of Sheffield
Sheffield, South Yorkshire, United Kingdom
Jonathan Graf, MD
Professor of Medicine, Division of Rheumatology
University of California, San Francisco
Zuckerberg San Francisco General
Steven T. Harris, MD, FACP
Clinical Professor of Medicine
Edward Hsiao, MD, PhD
Deborah Kado, MD
Wendy L. Katzman PT, DPTSc
Professor Emeritus School of Medicine
Department of Physical Therapy and Rehabilitation Science
Clifford J. Rosen, MD
Professor of Medicine
Tufts University School of Medicine
Maine Medical Center Research Institute
Scarborough, Maine
Ann V. Schwartz, PhD
Professor of Epidemiology and Biostatistics
University of California, San Francisco
Deborah E. Sellmeyer, MD
Clinical Professor of Medicine
Stanford University School of Medicine
Division of Endocrinology, Gerontology and Metabolism
Previous Courses